Special Report: 10 long-term picks for a short-term market (first seven picks)
(A word of apology. I hadn't realized that I had written about this Special Report but never posted it until several readers brought it to my attention last week. My initial reaction was "Impossible! Of course I'd posted it." But checking showed I hadn't. It took...
Riding the Popeye’s chicken sandwich higher; raising target price for Restaurant Brands International
Today I'm raising my target price for Restaurant Brands International (QSR) because I think the new Popeye's chicken sandwich has legs. A social media storm has accompanied the introduction of a new chicken sandwich at Popeye's to compete with Chick-fil-A that has led...
SolarEdge Technologies hits all time high on earnings beat, raising my target price in my Picks portfolio
Wednesday, August 7, SolarEdge Technologies (SEDG) reported second quarter revenue of $325 million, up 43% from the second quarter of 2018 and ahead of analyst projections of $315.5 million in revenue. Adjusted earnings rose 15% year over year to 94 cents a share,...
Adding Palo Alto Networks, #6 in my 10 Best Picks for the Rest of 2019, to my Jubak Picks and Volatility Portfolios tomorrow
Today I made Palo Alto Networks (PANW) the sixth pick in my Special Report 10 Best Picks for the Rest of 2019. Tomorrow, June 28, I'll add these shares to my Jubak Picks Portfolio and my Volatility Portfolio with a target price of $260. The stock closed at $204.89...
Raising target price on Tencent Holdings , #4 in my 10 Best Picks for the Next 6 months of 2019 Special Report
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
Adding Nektar call options to my Volatility Portfolio–again
Again. I'm adding the January 17, 2020 Call Options with a strike at $35 on Nektar Theraeutics (NKTR) to my Volatility Portfolio on JubakAM.com and JugglingWithKnives.com. (Ticker on these options is NKTR200117C00035000.) The underlying shares closed at $33.70, up...
I added Parsley Energy to my Jubak Picks Portfolio back on April 17–but neglected to post it to the portfolio
Back on April 17, I made Parsley Energy (PE) my first disruption in the oil sector pick in my Special Report on Disrupted Sectors. I didn't actually post that pick to the portfolio, however, and this post, excerpted from the Special Report, is a fix for that error....
Nektar Therapeutics bumps along ahead of August FDA action on new non-addictive opioid
Shares of Nektar Therapeutics (NKTR) have been bumping along between $32 and $34 for two months now, but the company continues to take steps to prepare for the likely August approval of NKTR-181, a new non-addictive opioid. Nektar has formed Inheris Biopharma, a...
Buying this Vanguard Treasury ETF on Monday for my ETF Portfolio–and for my Jubak Picks and Volatility portfolios
Today I sold the iShares MSCI Emerging Markets ETF (EEM) out of my Perfect 5 ETF Portfolio. And today I'm replacing it in that portfolio with the Vanguard Intermediate Term Treasury ETF (VGIT). Now obviously a Treasury bond ETF isn't in the same asset class as an...
Incyte adds to Jakafi label with new FDA approval
Jubak Picks and Volatility Portfolio member Incyte (INCY) closed up 1.55% today to $81.75 on news that the U.S. Food and Drug Administration had approved the company's Jakafi for treatment for acute Graft versus Host disease (GvHD), an inflammatory response by the...
So much for any infrastructure spending bill from Washington
President Donald Trump stormed out of a meeting with Democratic House Speaker Nancy Pelosi and Democratic Senate Minority Leader Chuck Schumer saying that he would not work with them on an infrastructure package (or other bipartisan legislation including an effort to...Jim’s Stock Alerts
Download Jim’s eBook for Free
